Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
WILMINGTON, Del., March 20, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised $787 million in financing rounds. The investment included participation by a...
Globe Teleservices Announces Partnership with Myanma Posts and Telecommunications to Enhance Secure Messaging and Customer Experience
SINGAPORE, March 11, 2026 /PRNewswire/ -- Globe Teleservices Pte. Ltd. (GTS), a global telecom solutions provider, announced its partnership with Myanma Posts and Telecommunications (MPT Myanmar), Myanmar's state-owned telecommunications operator,...
DoveRunner Expands Presence in Southeast Asia with New Office in Jakarta
JAKARTA, Indonesia, Feb. 25, 2026 /PRNewswire/ -- DoveRunner, a global leader in mobile application protection and content security technology, has announced the opening of its new office in Jakarta, Indonesia. This expansion reinforces DoveRunner's...
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful...
Fac Tec China 2026: Your Gateway to the Factories of Tomorrow - Driving Efficiency, Safety, and Sustainability
SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- Organized by RX, Fac Tec China will take place from June 2–4, 2026, at the Shanghai World Expo Exhibition & Convention Center. This premier trade event comes at a pivotal moment for the global electronics...
Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid Tumors
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy. NEWARK, Del. and NANJING, China, Feb. 3, 2026...
Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring
SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of its self-developed innovative anti-IL-11 monoclonal...
Solidion Technology Awarded A Second Grant From The U.S. Department of Energy For Nuclear Reactors
Grant Proceeds Will Accelerate Research Into Anti-Corrosive Additives in Molten-Salts-Based Heat Transfer Fluids For Nuclear Reactors. DALLAS, Dec. 29, 2025 /PRNewswire/ -- Solidion Technology Inc. ("Solidion" or the "Company") (Nasdaq: STI), an...
CGTN: Why China's anti-corruption drive never stops
CGTN published an article on China's ongoing anti-corruption campaign. The article explains how China's approach differs from Western models, highlights strict Party self-governance, and emphasizes that anti-corruption efforts ultimately serve the...
Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study
SHANGHAI, Dec. 24, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the U.S. Food and Drug Administration (FDA) for its...